There have been three intermediate grade s. aureus infections reported in the popular press. The one in Japan, one in Michigan last week, and one in Camden, NJ. The Michigan infection was due to physician mistakes: 1) they didn't do a sensitivity culture and missed the fact that this patient's infection was susceptible to four anti-biotics, including the ancient Tetracycline. 2) Hence, they repeatedly administered Vancomycin, beginning in January, 97, and eventually the patient's staph became resistant to it.
Does anyone know the treatment details in the Camden, NJ Vanco-resistant infection?
This is a little different from a wild bacteria sweeping the world, seen first in Japan, and then in Michigan and New Jersey. However, as CDC said, routine physician practices are causing bacterial mutations of this type. What will happen when one of these infections leaves the hospital? |
